Hatib, Fauzan S.
HRN: 23-52-04 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/11/2023
AMPICILLIN 500MG (VIAL)
08/11/2023
08/18/2023
IV
450mg
Q6hours
Pneumonia, Low Risk
Checking Final Appropriateness